본문 바로가기

AptoDetect™-Lung Assay as a Blood-Based Predictor of Advanced-Stage Lung Cancer in Patients with Lung-RADS 3-4 Pulmonary Nodules: A Multicenter Prospective Cohort Study

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
BIOMEDICINES14(5) · #1013 · 2026
피인용
Web of Science 0Scopus 0
FWCI (Scopus)
0
JCR IF
JCR 2024 3.9
ISSN
2227-9059

저자

  1. Lee, Bora제1저자Catholic Univ Korea, Eunpyeong St Marys Hosp, Coll Med, Dept Internal Med,Div Pulm Crit Care & Sleep Med, Seoul 03312, South Korea
  2. Kim, Chi YoungYonsei Univ, Gangnam Severance Hosp, Dept Internal Med, Div Pulmonol,Coll Med, Seoul 06273, South Korea
  3. 엄중섭Pusan Natl Univ, Sch Med, Dept Internal Med, Busan 49241, South Korea
  4. Ji, WonjunUniv Ulsan, Asan Med Ctr, Dept Internal Med, Div Pulmonol & Allergy,Coll Med, Seoul 05505, South Korea
  5. Kim, Min JeeUniv Ulsan, Asan Med Ctr, Dept Internal Med, Div Pulmonol & Allergy,Coll Med, Seoul 05505, South Korea
  6. 윤성훈Pusan Natl Univ, Yangsan Hosp, Sch Med, Dept Internal Med,Div Pulmonol, Yangsan 50612, South Korea
  7. Ahn, June HongYeungnam Univ, Coll Med, Med Ctr, Dept Internal Med,Div Pulmonol & Allergy, Daegu 42415, South Korea
  8. Lim, Jun HyeokInha Univ, Inha Univ Hosp, Dept Internal Med, Div Pulmonol,Sch Med, Incheon 22332, South Korea
  9. Chung, ChaeukChungnam Natl Univ, Coll Med, Dept Internal Med, Div Pulmonol & Crit Care Med, Daejeon 35015, South Korea
  10. Park, Dong WonHanyang Univ, Coll Med, Hanyang Univ Hosp, Dept Internal Med,Div Pulmonol & Allergy, Seoul 04763, South Korea
  11. Lee, Seung Hyeun교신저자Kyung Hee Univ, Coll Med, Dept Internal Med, Div Pulm Allergy & Crit Care Med, Seoul 02447, South Korea
  12. Yeo, Chang Dong교신저자Catholic Univ Korea, Eunpyeong St Marys Hosp, Coll Med, Dept Internal Med,Div Pulm Crit Care & Sleep Med, Seoul 03312, South Korea

초록

Background: The AptoDetect (TM)-Lung assay is an aptamer-based test designed for risk assessment in patients with pulmonary nodules, but its potential role in predicting lung cancer stage has not been evaluated. We investigated whether the assay could predict advanced-stage disease beyond conventional diagnostic modalities. Methods: This multicenter prospective cohort study enrolled 1672 patients with Lung-RADS 3-4 pulmonary nodules across ten university-affiliated hospitals in South Korea between June 2023 and December 2024. Among them, 934 patients with histologically confirmed lung cancer were retrospectively selected, and 852 patients were included in the final analysis after exclusions. The AptoDetect (TM)-Lung assay was performed before invasive diagnostic procedures. Results: Among the 852 patients, 450 (52.8%) had advanced-stage disease. The AptoDetect (TM)-Lung score was significantly higher in advanced-stage than in early-stage lung cancer (median, 6.2 vs. 2.8, p < 0.001). In a multivariable logistic regression analysis, a high AptoDetect (TM)-Lung score (>= 5) was independently associated with advanced disease (odds ratio 1.99, 95% confidence interval 1.35-2.95, p < 0.001). The AptoDetect (TM)-Lung assay showed moderate discrimination of advanced-stage disease (area under the curve [AUC] 0.696) and in non-small cell lung cancer (AUC 0.720), whereas its discriminative ability was limited in small cell lung cancer (AUC 0.561). A combined prediction model incorporating the AptoDetect (TM)-Lung assay, serum CEA, and radiologic findings demonstrated improved discriminative performance (AUC 0.821). Conclusions: The AptoDetect (TM)-Lung assay score was independently associated with advanced-stage lung cancer and could provide clinically useful information for early risk stratification before definitive diagnosis and staging are available.

키워드

lung cancerpulmonary nodulesbiomarkeraptamerdisease stagingSURVIVALCEABIOMARKERS

식별자

Scopus EID
2-s2.0-105040232537
WoS UID
001776515800001